Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sabinsa Corporation - Nutraceuticals World

What are you searching for?

Sign in
Regulations

Sabinsa Corporation

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Sabinsa Corporation, East Windsor, NJ, has received Product Information (PI) numbers for ForsLean 10% and 20% from Australia’s TGA (Therapeutic Goods Administration), a division of the Australian Government Department of Health and Ageing. Obtaining the PI numbers opens the door for ForsLean to enter the Australian market. The numbers are: 11628 Sabinsa Coleus Forslean (1) 26/04/2005, 107073 Sabinsa Coleus forskohlii extract 10%. Product Information (PI) provides health professionals with a summary of the essential scientific information about a therapeutic product, which requires information relating to its safe and effective use. Product Information documents are provided to and reviewed by the TGA as part of the approval process before a therapeutic product can be made available in Australia.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters